Diagnostics & Research
The Diagnostics & Research industry has a total of 44 stocks, with a combined market cap of $902.71 billion, total revenue of $177.12 billion and a weighted average PE ratio of 46.44.
Market Cap
902.71B
Revenue
177.12B
Profits
19.44B
PE Ratio
46.44
Profit Margin
10.97%
Dividend Yield
0.19%
44 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 254.47B | -0.66% | 1,583,749 | 47.35B |
| 2 | DHR | Danaher Corporation | 158.84B | -1.80% | 3,561,884 | 25.61B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 54.38B | -1.49% | 400,431 | 4.66B |
| 4 | A | Agilent Technologies, Inc. | 48.55B | -0.40% | 2,465,308 | 7.37B |
| 5 | WAT | Waters Corporation | 44.21B | -0.80% | 423,545 | 5.61B |
| 6 | IQV | IQVIA Holdings Inc. | 42.45B | -2.69% | 1,258,763 | 17.31B |
| 7 | NTRA | Natera, Inc. | 41.68B | -0.35% | 2,034,243 | 2.91B |
| 8 | MTD | Mettler-Toledo International Inc. | 34.07B | -0.83% | 130,014 | 4.20B |
| 9 | ILMN | Illumina, Inc. | 30.63B | 2.33% | 1,671,474 | 4.54B |
| 10 | LH | Labcorp Holdings Inc. | 29.90B | -1.13% | 715,288 | 14.59B |
| 11 | DGX | Quest Diagnostics Incorporated | 28.20B | -2.23% | 936,176 | 11.84B |
| 12 | GH | Guardant Health, Inc. | 19.38B | -0.52% | 1,960,146 | 1.28B |
| 13 | MEDP | Medpace Holdings, Inc. | 18.27B | 0.75% | 180,223 | 2.84B |
| 14 | RVTY | Revvity, Inc. | 16.50B | -0.71% | 1,177,110 | 2.94B |
| 15 | CRL | Charles River Laboratories International, Inc. | 15.92B | -1.00% | 697,545 | 3.98B |
| 16 | ICLR | ICON Public Limited Company | 14.61B | 1.89% | 662,786 | 8.23B |
| 17 | QGEN | Qiagen N.V. | 10.27B | -0.12% | 2,205,836 | 2.12B |
| 18 | RDNT | RadNet, Inc. | 5.90B | -2.56% | 393,567 | 2.38B |
| 19 | GRAL | GRAIL, Inc. | 4.76B | 0.27% | 699,646 | 166.60M |
| 20 | BLLN | BillionToOne, Inc. | 4.66B | 1.24% | 778,790 | 436.87M |
| 21 | ADPT | Adaptive Biotechnologies Corporation | 4.61B | 2.22% | 1,674,606 | 298.01M |
| 22 | SHC | Sotera Health Company | 4.58B | -1.23% | 2,611,725 | 1.23B |
| 23 | CDNA | CareDx, Inc. | 3.92B | 1.14% | 815,146 | 497.40M |
| 24 | NEO | NeoGenomics, Inc. | 1.97B | -1.04% | 1,033,361 | 787.75M |
| 25 | VCYT | Veracyte, Inc. | 1.96B | 0.92% | 3,056,156 | 581.78M |
| 26 | PSNL | Personalis, Inc. | 1.60B | 0.00% | 3,134,964 | 80.77M |
| 27 | WGS | GeneDx Holdings Corp. | 1.42B | -7.31% | 1,991,828 | 460.78M |
| 28 | OPK | OPKO Health, Inc. | 1.20B | 0.00% | 3,028,835 | 654.10M |
| 29 | FRNM | Freenome, Inc. | 1.06B | -2.68% | 528,506 | 217.86M |
| 30 | CSTL | Castle Biosciences, Inc. | 1.02B | 0.70% | 339,179 | 377.13M |
| 31 | FLGT | Fulgent Genetics, Inc. | 676.40M | 0.56% | 277,140 | 330.28M |
| 32 | MYGN | Myriad Genetics, Inc. | 531.41M | -0.54% | 1,119,062 | 803.60M |
| 33 | BNR | Burning Rock Biotech Limited | 131.83M | -1.88% | 36,110 | 73.70M |
| 34 | BDSX | Biodesix, Inc. | 98.47M | -1.33% | 131,125 | 105.21M |
| 35 | XGN | Exagen Inc. | 91.09M | -0.27% | 1,328,723 | 72.30M |
| 36 | IMDX | Insight Molecular Diagnostics Inc. | 58.25M | -4.30% | 1,202,666 | 1.97M |
| 37 | QUCY | Quantum Cyber N.V. | 52.40M | 6.55% | 328,454 | 1.50M |
| 38 | PRPO | Precipio, Inc. | 34.32M | -3.96% | 46,281 | 27.76M |
| 39 | MDXH | MDxHealth SA | 14.22M | 0.00% | 797,817 | 114.01M |
| 40 | NDRA | ENDRA Life Sciences Inc. | 5.88M | -11.31% | 16,961 | - |
| 41 | XWEL | XWELL, Inc. | 4.19M | -0.33% | 115,167 | 28.28M |
| 42 | BIAF | bioAffinity Technologies, Inc. | 3.51M | -3.50% | 67,866 | 5.53M |
| 43 | ADVB | Advanced Biomed Inc. | 3.47M | -5.41% | 21,821 | 127.64K |
| 44 | ISPC | iSpecimen Inc. | 3.45M | -1.45% | 41,944 | 466.30K |